| 000 | 01131 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514185932.0 | ||
| 264 | 0 | _c20040921 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0890-9091 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWong, Zee-Wan | |
| 245 | 0 | 0 |
_aNeoadjuvant endocrine therapy for breast cancer: an overlooked option? _h[electronic resource] |
| 260 |
_bOncology (Williston Park, N.Y.) _cApr 2004 |
||
| 300 |
_a411-20; discussion 421, 424, 429 passim p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 | _aAromatase Inhibitors |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 700 | 1 | _aEllis, Matthew J | |
| 773 | 0 |
_tOncology (Williston Park, N.Y.) _gvol. 18 _gno. 4 _gp. 411-20; discussion 421, 424, 429 passim |
|
| 999 |
_c14843943 _d14843943 |
||